Insider Activity of Aromando Andrew
According to the SEC Form 4 filings, Aromando Andrew, being in a position of
- Chief Business Officer at Oncolytics Biotech Inc.,оver the last 12 months, has bought 29600 shares for $25,418, and sold 0 shares,over all time since 2026-02-11, has bought 29600 shares for $25,418, and sold 0 shares.
Biography of Aromando Andrew
No biography is available at this moment.